It is also able to inhibit high glucose-induced proliferation, migration, and invasion of pancreatic cancer cells companied with reducing expression of urokinase plasminogen activator (uPA) (Cao et al., 2016), E-cadherin, and Glut-1 modulated by high glucose. The gene discussed is PLAU; the disease is pancreatic neoplasm.